Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Bausch Health Companies Inc (NYSE: BHC) closed at $7.42 down -1.72% from its previous closing price of $7.55. In other words, the price has decreased by -$1.72 from its previous closing price. On the day, 3.09 million shares were traded. BHC stock price reached its highest trading level at $7.62 during the session, while it also had its lowest trading level at $7.38.
Ratios:
For a deeper understanding of Bausch Health Companies Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 3.60 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.44. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 1.22.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Raymond James on July 10, 2024, initiated with a Mkt Perform rating and assigned the stock a target price of $8.
On September 20, 2023, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $9 to $16.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 04 ’24 when Carson Seana sold 6,313 shares for $9.80 per share. The transaction valued at 61,867 led to the insider holds 499,905 shares of the business.
Carson Seana sold 220 shares of BHC for $1,624 on Dec 05 ’23. The EVP, General Counsel now owns 382,925 shares after completing the transaction at $7.38 per share. On Nov 06 ’23, another insider, Carson Seana, who serves as the EVP, General Counsel of the company, sold 43 shares for $7.61 each. As a result, the insider received 327 and left with 384,836 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BHC now has a Market Capitalization of 2721633792 and an Enterprise Value of 25003632640. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30. Its current Enterprise Value per Revenue stands at 2.789 whereas that against EBITDA is 8.453.
Stock Price History:
Over the past 52 weeks, BHC has reached a high of $11.46, while it has fallen to a 52-week low of $6.05. The 50-Day Moving Average of the stock is 8.21%, while the 200-Day Moving Average is calculated to be -5.36%.
Shares Statistics:
For the past three months, BHC has traded an average of 2.80M shares per day and 3064550 over the past ten days. A total of 365.24M shares are outstanding, with a floating share count of 357.55M. Insiders hold about 2.52% of the company’s shares, while institutions hold 77.94% stake in the company. Shares short for BHC as of 1719532800 were 18444946 with a Short Ratio of 6.59, compared to 1717113600 on 17574191. Therefore, it implies a Short% of Shares Outstanding of 18444946 and a Short% of Float of 6.670000399999999.
Dividends & Splits
The stock’s 5-year Average Dividend Yield is 6.52.
